Abstract is: Peter Libby is an American physician, focusing in atherosclerosis, cardiology and preventive cardiology, currently the Mallinckrodt Professor of Medicine, Harvard Medical School at Brigham and Women's Hospital.
| human | Q5 |
| P268 | Bibliothèque nationale de France ID | 14592720g |
| P6178 | Dimensions author ID | 01340247126.38 |
| P227 | GND ID | 1203736770 |
| P2671 | Google Knowledge Graph ID | /g/11cjpbxpjz |
| P1960 | Google Scholar author ID | 1LgbXjEAAAAJ |
| P269 | IdRef ID | 057864160 |
| P213 | ISNI | 0000000110380041 |
| P11249 | KBR person ID | 14524365 |
| P244 | Library of Congress authority ID | n97803471 |
| P8189 | National Library of Israel J9U ID | 987007447487205171 |
| P1006 | Nationale Thesaurus voor Auteursnamen ID | 161563236 |
| P691 | NL CR AUT ID | xx0061654 |
| P1015 | NORAF ID | 1012658 |
| P1207 | NUKAT ID | n02045916 |
| P496 | ORCID iD | 0000-0002-1502-502X |
| P3987 | SHARE Catalogue author ID | 750680 |
| P10861 | Springer Nature person ID | 01340247126.38 |
| P214 | VIAF ID | 10097074 |
| P10832 | WorldCat Entities ID | E39PBJpYydc97GdrJrPBQjpQMP |
| P166 | award received | Ernst Jung Gold Medal for Medicine | Q29886456 |
| honorary doctorate at the Laval University | Q51527076 | ||
| The Louis and Artur Lucian Award in Cardiovascular Diseases | Q56192279 | ||
| ??? | Q126416282 | ||
| P27 | country of citizenship | United States of America | Q30 |
| P1343 | described by source | Medvik | Q99413897 |
| P69 | educated at | University of California, San Diego | Q622664 |
| P108 | employer | Tufts University | Q49120 |
| P734 | family name | Libby | Q36925188 |
| Libby | Q36925188 | ||
| Libby | Q36925188 | ||
| P735 | given name | Peter | Q2793400 |
| Peter | Q2793400 | ||
| P106 | occupation | university teacher | Q1622272 |
| cardiologist | Q3264451 | ||
| P21 | sex or gender | male | Q6581097 |
| Q42616070 | 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis |
| Q54214237 | A Rock and a Hard Place: Chiseling Away at the Multiple Mechanisms of Aortic Stenosis. |
| Q42679591 | A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages |
| Q36379556 | A guanidine-rich regulatory oligodeoxynucleotide improves type-2 diabetes in obese mice by blocking T-cell differentiation |
| Q40128384 | A guiding map for inflammation |
| Q48095930 | A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense |
| Q90847797 | A new opening on aortic stenosis: predicting prognosis with clonal haematopoiesis |
| Q24301534 | A novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signaling |
| Q37262627 | A randomized trial of rosuvastatin in the prevention of venous thromboembolism |
| Q37429273 | A winter's tale: report from the First Annual Canadian Biomarkers and Surrogate Endpoints Symposium |
| Q41864110 | Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. |
| Q35014273 | Activation of prostaglandin E2-EP4 signaling reduces chemokine production in adipose tissue |
| Q47782268 | Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment |
| Q52657277 | Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial |
| Q37563746 | Adaptive immunity and atherosclerosis |
| Q50120546 | Adaptive immunity in acute coronary syndromes: chicken or egg? |
| Q37353726 | Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling |
| Q36347695 | Adiponectin induces pro-inflammatory programs in human macrophages and CD4+ T cells |
| Q37444222 | Adiponectin inhibits allograft rejection in murine cardiac transplantation |
| Q36634314 | Adiponectin inhibits macrophage tissue factor, a key trigger of thrombosis in disrupted atherosclerotic plaques |
| Q37377610 | Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10 |
| Q53517343 | Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. |
| Q36389747 | Adiponectin: a key adipocytokine in metabolic syndrome |
| Q88176548 | All roads lead to IL-6: A central hub of cardiometabolic signaling |
| Q36803560 | Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice |
| Q40615190 | Angiotensin II-induced TLR4 mediated abdominal aortic aneurysm in apolipoprotein E knockout mice is dependent on STAT3. |
| Q46802781 | Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution |
| Q99556898 | Annexin A1-dependent tethering promotes extracellular vesicle aggregation revealed with single-extracellular vesicle analysis |
| Q90759644 | Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure |
| Q51245249 | Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes. |
| Q37893433 | Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases |
| Q38606033 | Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease |
| Q40319936 | Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells |
| Q40246222 | Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells |
| Q40220531 | Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappaB activation |
| Q41999917 | Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. |
| Q52813285 | Assisted Living in the Atheroma: Elderly Macrophages Promote Plaques. |
| Q46658441 | Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study |
| Q50175626 | Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging. |
| Q36352662 | Atherosclerosis and proteinase activation |
| Q36602802 | Atherosclerosis: Successes, Surprises, and Future Challenges |
| Q36684354 | Atherosclerosis: disease biology affecting the coronary vasculature |
| Q28192780 | Atherosclerosis: the new view |
| Q36791618 | Atherosclerosis: the path from genomics to therapeutics |
| Q35789825 | Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology |
| Q35777759 | Atherosclerotic plaque inflammation: the final frontier? |
| Q42705355 | Augmented expression and activity of extracellular matrix-degrading enzymes in regions of low endothelial shear stress colocalize with coronary atheromata with thin fibrous caps in pigs |
| Q104111461 | Author Correction: A guiding map for inflammation |
| Q96950878 | Author Correction: Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease |
| Q44851046 | B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice |
| Q38478653 | Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein |
| Q35795164 | Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice |
| Q28088555 | Biomarkers: A Challenging Conundrum in Cardiovascular Disease |
| Q44714962 | C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro |
| Q54610913 | C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. |
| Q38444421 | C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy |
| Q46460917 | CADASIL mutations impair Notch3 glycosylation by Fringe |
| Q34378583 | CC chemokine receptor-1 activates intimal smooth muscle-like cells in graft arterial disease |
| Q43145952 | CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis |
| Q51798890 | CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. |
| Q48216696 | CD74 Deficiency Mitigates Systemic Lupus Erythematosus-like Autoimmunity and Pathological Findings in Mice. |
| Q57154282 | CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease |
| Q57823938 | CHIP (Clonal Hematopoiesis of Indeterminate Potential) |
| Q100696451 | COVID-19 - A Vascular Disease |
| Q33915626 | CXCR3 controls T-cell accumulation in fat inflammation |
| Q60924001 | Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key? |
| Q34547253 | Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis |
| Q34293369 | Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial |
| Q35121150 | Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions |
| Q38424497 | Cardiovascular drug development: is it dead or just hibernating? |
| Q35090566 | Cardiovascular remodelling in coronary artery disease and heart failure |
| Q28245234 | Cathepsin G activity lowers plasma LDL and reduces atherosclerosis |
| Q34978499 | Cathepsin G deficiency reduces periaortic calcium chloride injury-induced abdominal aortic aneurysms in mice |
| Q48348409 | Cathepsin K Deficiency Ameliorates Systemic Lupus Erythematosus-like Manifestations in Faslpr Mice. |
| Q35592574 | Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice |
| Q34654358 | Cathepsin L activity controls adipogenesis and glucose tolerance |
| Q35851900 | Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice |
| Q42480510 | Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells |
| Q37187482 | Cathepsin S-mediated fibroblast trans-differentiation contributes to left ventricular remodelling after myocardial infarction |
| Q35013298 | Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease |
| Q33864613 | Chronic variable stress activates hematopoietic stem cells |
| Q92578736 | Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease |
| Q53060833 | Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice. |
| Q35788816 | Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy in non-immunosuppressed hosts |
| Q37052925 | Collagenases and cracks in the plaque |
| Q52984131 | Combined non-invasive assessment of endothelial shear stress and molecular imaging of inflammation for the prediction of inflamed plaque in hyperlipidaemic rabbit aortas. |
| Q124479244 | Coronary Artery Calcification: Current Concepts and Clinical Implications |
| Q47242952 | Coronary Plaque Microstructure and Composition Modify Optical Polarization: A New Endogenous Contrast Mechanism for Optical Frequency Domain Imaging |
| Q47933695 | Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy |
| Q37375537 | Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation |
| Q45226535 | Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice |
| Q33947334 | Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice |
| Q52573372 | Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials. |
| Q37871766 | Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infection |
| Q34082315 | Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice |
| Q34967612 | Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice |
| Q34514569 | Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation. |
| Q35781497 | Deletion of the phosphoinositide 3-kinase p110gamma gene attenuates murine atherosclerosis |
| Q34646074 | Diabetes and atherosclerosis: epidemiology, pathophysiology, and management |
| Q44228460 | Diabetic macrovascular disease: the glucose paradox? |
| Q47671901 | Differences in Safety of Non-Steroidal Anti-Inflammatory Drugs in Patients with Osteoarthritis and Rheumatoid Arthritis: A Randomized Clinical Trial |
| Q47613653 | Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measure |
| Q44601106 | Direct Anti-Inflammatory Mechanisms Contribute to Attenuation of Experimental Allograft Arteriosclerosis by Statins |
| Q124479226 | Do patients benefit from omega-3 fatty acids? |
| Q35800476 | EP4 Receptor-Associated Protein in Macrophages Ameliorates Colitis and Colitis-Associated Tumorigenesis |
| Q92906442 | Editorial commentary: Arson in the artery: Who set the atheroma aflame? |
| Q52577312 | Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen |
| Q53924066 | Effect of a cleavage-resistant collagen mutation on left ventricular remodeling. |
| Q34366640 | Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial |
| Q44606908 | Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study |
| Q38601785 | Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial |
| Q34501729 | Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial |
| Q92303308 | Effects of Interleukin-1β Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory Risk: A Secondary Analysis of CANTOS |
| Q90595127 | Effects of Interleukin-1β Inhibition on Incident Anemia: Exploratory Analyses From a Randomized Trial |
| Q45369180 | Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial |
| Q35050141 | Effects of statins in reducing thrombotic risk and modulating plaque vulnerability. |
| Q44342162 | Elastogenesis in human arterial disease: a role for macrophages in disordered elastin synthesis |
| Q44438462 | Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones |
| Q46820939 | Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products |
| Q52728801 | Elevations in neutrophils with obstructive sleep apnea: The Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q46036776 | Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study. |
| Q35103442 | Enhanced expression of CD44 variants in human atheroma and abdominal aortic aneurysm: possible role for a feedback loop in endothelial cells |
| Q40594061 | Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation |
| Q44818823 | Examining the dyslipidemia constellation: an interactive forum on new treatment advances. Introduction |
| Q91174557 | Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells |
| Q42944624 | Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis |
| Q35687871 | Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions |
| Q51019502 | Factors underlying regression of coronary atheroma with potent statin therapy. |
| Q52934295 | Fanning the flames: inflammation in cardiovascular diseases. |
| Q27026646 | Fish oil and post-operative atrial fibrillation: a meta-analysis of randomized controlled trials |
| Q36960923 | Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial |
| Q43129657 | Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K. |
| Q35552554 | From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. |
| Q35558849 | From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. |
| Q38666411 | Fundamental Cardiovascular Research: Returns on Societal Investment: A Scientific Statement From the American Heart Association |
| Q27314193 | Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques |
| Q37330834 | Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice |
| Q53884073 | Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques. |
| Q34100760 | Genetically engineered resistance for MMP collagenases promotes abdominal aortic aneurysm formation in mice infused with angiotensin II |
| Q36691050 | Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis |
| Q36755904 | Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis |
| Q91284106 | Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease |
| Q38467184 | HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial |
| Q44585429 | High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study |
| Q34412168 | High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis |
| Q36989093 | Highlights of 10 years of immunology in Nature Reviews Immunology |
| Q43162246 | How does lipid lowering prevent coronary events? New insights from human imaging trials |
| Q44895729 | Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis |
| Q53229487 | Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. |
| Q24649151 | Identification of splenic reservoir monocytes and their deployment to inflammatory sites |
| Q34002717 | Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group |
| Q33991483 | IgE actions on CD4+ T cells, mast cells, and macrophages participate in the pathogenesis of experimental abdominal aortic aneurysms |
| Q35187080 | IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice |
| Q58081551 | IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice |
| Q36006065 | Imaging Granzyme B Activity Assesses Immune-Mediated Myocarditis |
| Q36202794 | Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis |
| Q37150605 | Immune effector mechanisms implicated in atherosclerosis: from mice to humans |
| Q39982049 | Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. |
| Q34735484 | In vivo nanoparticle assessment of pathological endothelium predicts the development of inflow stenosis in murine arteriovenous fistula |
| Q37710952 | In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. |
| Q33703129 | Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging |
| Q48004886 | Increased intermediate CD14++CD16++ monocyte subset levels associate with restenosis after peripheral percutaneous transluminal angioplasty |
| Q34543441 | Increased microvascularization and vessel permeability associate with active inflammation in human atheromata |
| Q45991963 | Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression. |
| Q30472773 | Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques |
| Q38289775 | Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. |
| Q89477733 | Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease |
| Q35721270 | Inflammation and atherosclerosis: role of C-reactive protein in risk assessment |
| Q36392615 | Inflammation and cardiovascular disease mechanisms |
| Q36404719 | Inflammation and cellular immune responses in abdominal aortic aneurysms |
| Q34988232 | Inflammation and immunity in diseases of the arterial tree: players and layers |
| Q33834800 | Inflammation and its resolution as determinants of acute coronary syndromes |
| Q124479221 | Inflammation and the pathogenesis of atherosclerosis |
| Q49936134 | Inflammation and thrombosis - testing the hypothesis with anti-inflammatory drug trials |
| Q36174933 | Inflammation in atherosclerosis |
| Q33709505 | Inflammation in atherosclerosis: from pathophysiology to practice |
| Q37045449 | Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction |
| Q37672113 | Inflammation in atherosclerosis: transition from theory to practice |
| Q79792625 | Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo |
| Q36738686 | Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists |
| Q57797462 | Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week |
| Q35789870 | Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? |
| Q44933960 | Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study |
| Q36701757 | Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study |
| Q37073872 | Inflammatory mechanisms: the molecular basis of inflammation and disease |
| Q43851368 | Influence of Helicobacter pylori infection during atherogenesis in vivo in mice |
| Q100413059 | Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial |
| Q88791363 | Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease |
| Q33659705 | Innate and adaptive immunity in atherosclerosis |
| Q34794757 | Innate and adaptive immunity in the pathogenesis of atherosclerosis |
| Q38932181 | Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity |
| Q41834087 | Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity |
| Q50710469 | Interferon-γ Released by Activated CD8+ T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves. |
| Q47599422 | Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond |
| Q91514025 | Interleukin-1β Mediates Arterial Thrombus Formation via NET-Associated Tissue Factor |
| Q85063666 | Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) |
| Q58698811 | Internal Bleeding: Is Intraplaque Hemorrhage a Decoration or a Driver? |
| Q36667645 | Intertwining of thrombosis and inflammation in atherosclerosis |
| Q37375680 | Kruppel-like factor KLF10 targets transforming growth factor-beta1 to regulate CD4(+)CD25(-) T cells and T regulatory cells |
| Q34410269 | Lack of EP4 receptors on bone marrow-derived cells enhances inflammation in atherosclerotic lesions |
| Q36348873 | Leptin Deficiency Shifts Mast Cells toward Anti-Inflammatory Actions and Protects Mice from Obesity and Diabetes by Polarizing M2 Macrophages |
| Q36808798 | Leukocyte integrin Mac-1 promotes acute cardiac allograft rejection |
| Q36654171 | Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum". |
| Q35141379 | Liberation of desmosine and isodesmosine as amino acids from insoluble elastin by elastolytic proteases |
| Q91764096 | Linking regulation of nitric oxide to endothelin-1: The Yin and Yang of vascular tone in the atherosclerotic plaque |
| Q46200093 | Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma |
| Q36110619 | Lipid lowering therapy in atherosclerosis |
| Q36228904 | Local cytokine environments drive aneurysm formation in allografted aortas |
| Q37161176 | Local proliferation dominates lesional macrophage accumulation in atherosclerosis |
| Q89790500 | Long noncoding RNA SNHG12 integrates a DNA-PK-mediated DNA damage response and vascular senescence |
| Q35751879 | Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection |
| Q92980641 | Low-Dose Methotrexate for the Prevention of Atherosclerotic Events |
| Q28388609 | Lp-PLA2 Antagonizes Left Ventricular Healing After Myocardial Infarction by Impairing the Appearance of Reparative Macrophages |
| Q35251005 | Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata |
| Q33596007 | Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium |
| Q35792643 | Lysosomal cysteine proteases in atherosclerosis |
| Q44936555 | Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice |
| Q46086580 | Macrophage migration inhibitory factor is associated with aneurysmal expansion |
| Q36990315 | Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques |
| Q51041551 | Macrophages Facilitate Electrical Conduction in the Heart. |
| Q35289180 | Macrophages retain hematopoietic stem cells in the spleen via VCAM-1 |
| Q35024817 | Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation |
| Q36025276 | Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice |
| Q46771682 | Matrix-metalloproteinase-14 deficiency in bone-marrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques |
| Q38812800 | Mechanisms of Myeloid Cell Modulation of Atherosclerosis |
| Q59744920 | Mechanisms of Plaque Progression and Complications |
| Q38108628 | Mechanisms of acute coronary syndromes and their implications for therapy |
| Q35077211 | Mechanisms of plaque stabilization with statins |
| Q34403101 | Moderate hypoxia potentiates interleukin-1β production in activated human macrophages |
| Q57182634 | Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) |
| Q36437431 | Molecular and cellular imaging of atherosclerosis: emerging applications |
| Q37173216 | Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis |
| Q36141999 | Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development |
| Q33887957 | Molecular imaging of atherosclerosis: a progress report |
| Q53466788 | Molecular imaging of cardiovascular disease. |
| Q41782452 | Molecular imaging of innate immune cell function in transplant rejection |
| Q34772143 | Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease |
| Q26991973 | Monocyte heterogeneity in cardiovascular disease |
| Q33450605 | Monocyte subset dynamics in human atherosclerosis can be profiled with magnetic nano-sensors |
| Q44149442 | Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice |
| Q46643118 | Murine "model" monotheism: an iconoclast at the altar of mouse |
| Q24650933 | Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI ... |
| Q24627504 | Myeloid-related protein-8/14 is critical for the biological response to vascular injury |
| Q35589891 | Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells |
| Q36106602 | Myocardial infarction accelerates atherosclerosis. |
| Q37072784 | Nanoparticle PET-CT detects rejection and immunomodulation in cardiac allografts |
| Q43153036 | Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. |
| Q44456362 | Neutrophil elastase in human atherosclerotic plaques: production by macrophages |
| Q50126843 | Nonculprit Plaque Characteristics in Patients With Acute Coronary Syndrome Caused by Plaque Erosion vs Plaque Rupture: A 3-Vessel Optical Coherence Tomography Study. |
| Q30488574 | Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions |
| Q56894441 | Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis |
| Q38820432 | North American Thrombosis Forum, AF Action Initiative Consensus Document |
| Q38376809 | Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prev |
| Q37462172 | Obesity, inflammation, and atherosclerosis |
| Q58816186 | Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor |
| Q37440343 | Optical and multimodality molecular imaging: insights into atherosclerosis |
| Q36141379 | Oxidative Stress Biomarkers and Incidence of Postoperative Atrial Fibrillation in the Omega-3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) Trial |
| Q42528357 | Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells |
| Q34509964 | PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis |
| Q34429470 | Pathophysiology of coronary artery disease |
| Q119146096 | Pathway-Specific Polygenic Risk Scores Identify Obstructive Sleep Apnea-Related Pathways Differentially Moderating Genetic Susceptibility to Coronary Artery Disease |
| Q48419452 | Peter Libby, MD: a conversation with the editor |
| Q50063033 | Plaque erosion: a new in vivo diagnosis and a potential major shift in the management of patients with acute coronary syndromes. |
| Q36663521 | Plaque stabilization: Can we turn theory into evidence? |
| Q40152738 | Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: a prospective, nested case-control study |
| Q35140370 | Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial |
| Q28238975 | Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events |
| Q51741649 | Pleiotropic Anti-atherosclerotic Effects of PCSK9 InhibitorsFrom Molecular Biology to Clinical Translation. |
| Q36676028 | Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research: National Heart, Lung, and Blood Institute Working Group |
| Q36650658 | Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques |
| Q34858516 | Progression of atheroma: a struggle between death and procreation |
| Q41728608 | Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure. |
| Q24313175 | Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation |
| Q44127968 | Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor |
| Q37445494 | RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction. |
| Q35679591 | Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis |
| Q37466366 | Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis |
| Q57820905 | Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study |
| Q46068912 | Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis |
| Q37311936 | Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis |
| Q38473723 | Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial |
| Q35975645 | Redundancy of IL-1 Isoform Signaling and Its Implications for Arterial Remodeling |
| Q36027826 | Regulatory T cells in human and angiotensin II-induced mouse abdominal aortic aneurysms |
| Q38467359 | Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). |
| Q47394886 | Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial |
| Q57455618 | Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial |
| Q46335538 | Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study |
| Q39973571 | Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myo |
| Q35058188 | Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging |
| Q36176985 | Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus |
| Q28082758 | Requiem for the 'vulnerable plaque' |
| Q90026895 | Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis |
| Q37300182 | Role of inflammation in atherosclerosis associated with rheumatoid arthritis |
| Q59114855 | Roles of PAD4 and NETosis in Experimental Atherosclerosis and Arterial Injury: Implications for Superficial Erosion |
| Q45940744 | Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study). |
| Q44941145 | Seeing and Sampling the Surface of the Atherosclerotic Plaque: Red or White Can Make Blue |
| Q38909951 | Selective cathepsin S inhibition attenuates atherosclerosis in apolipoprotein E-deficient mice with chronic renal disease |
| Q35433466 | Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis |
| Q91167278 | Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis |
| Q40880886 | Self-renewing resident arterial macrophages arise from embryonic CX3CR1(+) precursors and circulating monocytes immediately after birth |
| Q51112108 | Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN. |
| Q35737489 | Silencing of CCR2 in myocarditis |
| Q78780749 | Soluble CD40 ligand levels indicate lipid accumulation in carotid atheroma: an in vivo study with high-resolution MRI |
| Q40568978 | Soluble CD40L: risk prediction after acute coronary syndromes |
| Q33529582 | Spatiotemporal controlled delivery of nanoparticles to injured vasculature |
| Q34986368 | Stabilization of atherosclerotic plaques: new mechanisms and clinical targets |
| Q27317154 | Statins improve the resolution of established murine venous thrombosis: reductions in thrombus burden and vein wall scarring |
| Q44136766 | Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol |
| Q47246007 | Superficial erosion and the precision management of acute coronary syndromes: not one-size-fits-all |
| Q49793907 | Swell, or Not Too Swell: Cytokines Regulate Arterial Aneurysm Formation |
| Q35747563 | T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm |
| Q30485602 | T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) mice |
| Q35690744 | TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion |
| Q50081205 | Taming Immune and Inflammatory Responses to Treat Atherosclerosis. |
| Q36296699 | Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction |
| Q92026387 | Targeting RNA to lower triglycerides: long strides from short molecules |
| Q114870969 | Targeting inflammation in atherosclerosis — from experimental insights to the clinic |
| Q38985960 | Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease |
| Q41062476 | Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas |
| Q39089802 | The "Intermediate" CD14++CD16+ monocyte subset increases in severe peripheral artery disease in humans |
| Q112724209 | The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis |
| Q39241083 | The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels |
| Q34990556 | The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease |
| Q51822430 | The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. |
| Q36274303 | The forgotten majority: unfinished business in cardiovascular risk reduction |
| Q36392644 | The future of living well to 100. |
| Q36508676 | The immune response in atherosclerosis: a double-edged sword |
| Q47696973 | The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes |
| Q36743196 | The inflammation hypothesis and its potential relevance to statin therapy |
| Q37282249 | The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models |
| Q37085945 | The multiple facets of the fat tissue |
| Q104799704 | The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials |
| Q92522639 | The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction |
| Q37731750 | The vascular biology of atherosclerosis and imaging targets |
| Q35744631 | The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach |
| Q35100790 | The ω-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation trial--rationale and design |
| Q35539710 | Therapeutic siRNA silencing in inflammatory monocytes in mice |
| Q38274882 | Thin-capped atheromata with reduced collagen content in pigs develop in coronary arterial regions exposed to persistently low endothelial shear stress |
| Q53445010 | Thoughts on the role of the healing professions and the events of September 11, 2001. |
| Q50243848 | Tilting at the tilted protease balance in arterial aneurysmal disease. |
| Q113078307 | Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects |
| Q91301141 | Tissue-Specific Macrophage Responses to Remote Injury Impact the Outcome of Subsequent Local Immune Challenge |
| Q39922985 | Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation |
| Q35753514 | Triglycerides on the rise: should we swap seats on the seesaw? |
| Q34369244 | Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall |
| Q41960384 | Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury |
| Q47679652 | Unfriendly Fire From Neutrophils Promiscuously Potentiates Cardiovascular Inflammation |
| Q35088517 | Vascular biology of atherosclerosis: overview and state of the art. |
| Q53253607 | Vascular biomarkers and surrogates in cardiovascular disease. |
| Q36790459 | Vascular remodeling in transplant vasculopathy |
| Q35146439 | Vasospasm of atherosclerotic coronary arteries precipitates acute ischemic myocardial damage in myocardial infarction-prone strain of the Watanabe heritable hyperlipidemic rabbits |
| Q43933058 | Vitamin C, collagen, and cracks in the plaque |
| Q31092315 | Wild-type but not interferon-gamma-deficient T cells induce graft arterial disease in the absence of B cells |
| Q89950977 | Beryl R Benacerraf | spouse | P26 |
| Arabic (ar / Q13955) | بيتر ليبي | wikipedia |
| Peter Libby | wikipedia | |
| Peter Libby | wikipedia |
Search more.